Regeneron Covid-19 antibody may help speed recovery, early data show
Experts caution more data from larger trials will be needed to know how potentially beneficial monoclonal antibodies are.
Experts caution more data from larger trials will be needed to know how potentially beneficial monoclonal antibodies are.
Decades of declining heart failure mortality in the U.S. has reversed, and exceeded rates recorded more than 20 years ago, according to overall population-level data…
This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.
This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.
In heart failure, “the paradox is that at a time that we’re seeing these increases in mortality, we also have access to better medications,” Mount…
In heart failure, “the paradox is that at a time that we’re seeing these increases in mortality, we also have access to better medications,” Mount…
This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.
This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.
AbstractBackgroundMineralocorticoid receptor antagonists (MRAs) are underused in patients with kidney dysfunction, and their efficacy among patients with chronic kidney disease (CKD) is uncertain.O…
ESC Heart Failure is the open access journal of the ESC Heart Failure Association, dedicated to the advancement of knowledge in the field of heart…
ESC Heart Failure is the open access journal of the ESC Heart Failure Association, dedicated to the advancement of knowledge in the field of heart…